#Melanoma

Explore our comprehensive coverage of melanoma, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

2Articles

1Authors

32Total Views

Breakthrough in Oncology: Novel mRNA Cancer Vaccine Demonstrates 85% Efficacy in Phase 3 Trials

Featured

By Katherine Anne WhitfieldJul 28, 2026

Breakthrough in Oncology: Novel mRNA Cancer Vaccine Demonstrates 85% Efficacy in Phase 3 Trials

Researchers at the University of Cambridge have announced groundbreaking Phase 3 trial results for a novel mRNA-based cancer vaccine, demonstrating an...

Read Full Story →

Recent Articles

FDA Fast-Tracks Moderna-Merck mRNA Cancer Vaccine After Phase 3 Melanoma Trial Shows 65% Recurrence Drop

Medical Research

Jun 19, 20265 min

FDA Fast-Tracks Moderna-Merck mRNA Cancer Vaccine After Phase 3 Melanoma Trial Shows 65% Recurrence Drop

The US FDA has fast-tracked the Moderna-Merck personalized mRNA cancer vaccine after Phase 3 trials ...

Katherine Anne Whitfield💬 0